Advertisement

Spine


From more follow-up data on artificial disc replacement to new sources of stem cells for spinal fusion procedures, here are five recent studies drawing attention from spine surgeons:

From innovations in biologic treatments to physician advocacy and migrating cases to the outpatient setting, nine spine surgeons discuss the biggest opportunities in the field today.

ASC investment is top of mind for some spine surgeons as more procedures migrate to the outpatient setting. However, it might not be the best move for everyone.

Advertisement